chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Insomnia, Leukocytosis, Malaise, Metastases to lymph nodes, Nausea
Clinical narrative: Hospitalized;  COVID-19 positive (9.5.21);  fully vaccinated Admission Date: 9/6/2021 Discharge Date: 09/08/2021 Patient's Discharge Disposition:  Home in stable condition. DISCHARGE DIAGNOSES:   1. Sepsis, UTI 2. Non-neutropenic fevers 3. Covid-19 positive 4. AKI 5. Metastatic neuroendocrine carcinoma of Retroperitoneal Mass with pelvic lymph mets 6. Metastatic invasive urothelial carcinoma  7. HTN 8. HLD 9. Insomnia Hospital course:   This is a 69 yo male with a history of neuroendocrine carcinoma of pelvis mass diagnosed 7/8/21 and on active treatment with VP16/cisplatin. He completed cycle 2 on 9/2/21. He also has a history of urothelial carcinoma s/p RURBT 3/22/19 and cystoprostatectomy 11/2020, CAD, OSA, HLD. He had presented to Metro ED on 9/5/21 with a fever, nausea and malaise. Work-up was started with blood cultures, IV antibiotics but the patient eventually left AMA due to bed shortage from Metro. Then on 9/6/21 he presented to SH BWH ED. He had  Leukocytosis and fevers. His COVID PCR from 9/5 was positive. The patient was admitted for sepsis, likely from COVID-19. UA appeared positive and urine culture is still pending. Patient was started on Zosyn. ID was consulted for evaluation. The patient did not meet criteria for monoclonal antibodies for Covid. His fevers improved and his blood cultures are negative at 48hrs. Per discussion with ID patient is okay to discharge home today, and with zosyn has been treated for UTI, although cultures will be followed-up outpatient. The patient had diarrhea but it improved prior to cdiff sample could be collected. He had a mild AKI on admission which has improve with IVF. The patient's WBC normalized and his vitals are stable. He is discharging home in stable condition. He will follow-up in the office on 9/16 with labs and Doctor. Nurse coordinator to f/u on urine culture after discharge.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Neuroendocrine carcinoma, Pyrexia, Retroperitoneal mass, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Hospitalized;  COVID-19 positive (9.5.21);  fully vaccinated Admission Date: 9/6/2021 Discharge Date: 09/08/2021 Patient's Discharge Disposition:  Home in stable condition. DISCHARGE DIAGNOSES:   1. Sepsis, UTI 2. Non-neutropenic fevers 3. Covid-19 positive 4. AKI 5. Metastatic neuroendocrine carcinoma of Retroperitoneal Mass with pelvic lymph mets 6. Metastatic invasive urothelial carcinoma  7. HTN 8. HLD 9. Insomnia Hospital course:   This is a 69 yo male with a history of neuroendocrine carcinoma of pelvis mass diagnosed 7/8/21 and on active treatment with VP16/cisplatin. He completed cycle 2 on 9/2/21. He also has a history of urothelial carcinoma s/p RURBT 3/22/19 and cystoprostatectomy 11/2020, CAD, OSA, HLD. He had presented to Metro ED on 9/5/21 with a fever, nausea and malaise. Work-up was started with blood cultures, IV antibiotics but the patient eventually left AMA due to bed shortage from Metro. Then on 9/6/21 he presented to SH BWH ED. He had  Leukocytosis and fevers. His COVID PCR from 9/5 was positive. The patient was admitted for sepsis, likely from COVID-19. UA appeared positive and urine culture is still pending. Patient was started on Zosyn. ID was consulted for evaluation. The patient did not meet criteria for monoclonal antibodies for Covid. His fevers improved and his blood cultures are negative at 48hrs. Per discussion with ID patient is okay to discharge home today, and with zosyn has been treated for UTI, although cultures will be followed-up outpatient. The patient had diarrhea but it improved prior to cdiff sample could be collected. He had a mild AKI on admission which has improve with IVF. The patient's WBC normalized and his vitals are stable. He is discharging home in stable condition. He will follow-up in the office on 9/16 with labs and Doctor. Nurse coordinator to f/u on urine culture after discharge.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Transitional cell carcinoma, Urinary tract infection, Urine analysis abnormal, White blood cell count
Clinical narrative: Hospitalized;  COVID-19 positive (9.5.21);  fully vaccinated Admission Date: 9/6/2021 Discharge Date: 09/08/2021 Patient's Discharge Disposition:  Home in stable condition. DISCHARGE DIAGNOSES:   1. Sepsis, UTI 2. Non-neutropenic fevers 3. Covid-19 positive 4. AKI 5. Metastatic neuroendocrine carcinoma of Retroperitoneal Mass with pelvic lymph mets 6. Metastatic invasive urothelial carcinoma  7. HTN 8. HLD 9. Insomnia Hospital course:   This is a 69 yo male with a history of neuroendocrine carcinoma of pelvis mass diagnosed 7/8/21 and on active treatment with VP16/cisplatin. He completed cycle 2 on 9/2/21. He also has a history of urothelial carcinoma s/p RURBT 3/22/19 and cystoprostatectomy 11/2020, CAD, OSA, HLD. He had presented to Metro ED on 9/5/21 with a fever, nausea and malaise. Work-up was started with blood cultures, IV antibiotics but the patient eventually left AMA due to bed shortage from Metro. Then on 9/6/21 he presented to SH BWH ED. He had  Leukocytosis and fevers. His COVID PCR from 9/5 was positive. The patient was admitted for sepsis, likely from COVID-19. UA appeared positive and urine culture is still pending. Patient was started on Zosyn. ID was consulted for evaluation. The patient did not meet criteria for monoclonal antibodies for Covid. His fevers improved and his blood cultures are negative at 48hrs. Per discussion with ID patient is okay to discharge home today, and with zosyn has been treated for UTI, although cultures will be followed-up outpatient. The patient had diarrhea but it improved prior to cdiff sample could be collected. He had a mild AKI on admission which has improve with IVF. The patient's WBC normalized and his vitals are stable. He is discharging home in stable condition. He will follow-up in the office on 9/16 with labs and Doctor. Nurse coordinator to f/u on urine culture after discharge.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Pyrexia
Clinical narrative: 9/13/21: Patient arrived at the ER due to shortness of breath getting progressively worse over the last 3 hours. Patient was given breathing treatment at home by family, with no improvement. She just also received her flu vaccine on 09/10/2021.  She endorses mild fevers at home. Patient received first dose Pfizer vaccine on 3/15/2021 Lot # EN6198 and the second dose on 4/05/2021 Lot # EN62060
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest discomfort, Cough, Dyspnoea, Dyspnoea exertional
Clinical narrative: 9/13/21: Patient arrived at the ER due to worsening cough and shortness of breath.  Per patient she returned from traveling on last Tuesday and since then experiencing worsening shortness of breath with exertion and dry cough.  Associated with chest tightness and congestion and fatigue.  The patient also reported recurring fevers.  The patient was exposed to COVID-19 cases while traveling.  The patient went to Clinic on Friday, COVID test was negative and the patient was started on doxycycline.  Despite taking the medication her symptoms were getting worse therefore she decided to come to the ER. Patient tested positive for COVID on 9/13/21.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: 9/13/21: Patient arrived at the ER due to worsening cough and shortness of breath.  Per patient she returned from traveling on last Tuesday and since then experiencing worsening shortness of breath with exertion and dry cough.  Associated with chest tightness and congestion and fatigue.  The patient also reported recurring fevers.  The patient was exposed to COVID-19 cases while traveling.  The patient went to Clinic on Friday, COVID test was negative and the patient was started on doxycycline.  Despite taking the medication her symptoms were getting worse therefore she decided to come to the ER. Patient tested positive for COVID on 9/13/21.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebral ischaemia, Cerebrovascular accident, Embolic stroke, Hemiparesis, Internal capsule infarction
Clinical narrative: Patient received 2nd dose of COVID vaccine on 9/11/21.  Presented to hospital on 9/13/21 with worsening right-sided weakness.  Teleneurology consult assessment with findings of "stroke, probably left posterior limp interal capsule/small vessel."
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging head abnormal
Clinical narrative: Patient received 2nd dose of COVID vaccine on 9/11/21.  Presented to hospital on 9/13/21 with worsening right-sided weakness.  Teleneurology consult assessment with findings of "stroke, probably left posterior limp interal capsule/small vessel."
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Body temperature increased, Headache, Pain
Clinical narrative: Unsure of vaccine manufacturer and lot data. High temperature (104) through the night. Soreness. Headache. Temperature partially responded to ibuprofen and cold shower.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Blood thyroid stimulating hormone normal, C-reactive protein normal, Chest pain, Electrocardiogram normal, Full blood count normal
Clinical narrative: Patient reports that she received her 2nd Pfizer COVID vaccine Saturday and woke up in the early AM Sunday with chest pain, her head "feeling tingly" and heart rate feeling like it was going fast sometimes and slow sometimes.    Presented to the office on Monday AM with symptoms persisting
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Metabolic function test, Palpitations, Paraesthesia, Red blood cell sedimentation rate normal, Troponin normal
Clinical narrative: Patient reports that she received her 2nd Pfizer COVID vaccine Saturday and woke up in the early AM Sunday with chest pain, her head "feeling tingly" and heart rate feeling like it was going fast sometimes and slow sometimes.    Presented to the office on Monday AM with symptoms persisting
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Pain
Clinical narrative: Feeling of stuffiness in left frontal lobe of brain.  Dull ache no headache.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain in extremity, Paraesthesia, Peripheral swelling, Tenderness
Clinical narrative: I have pain, swelling, numbness and tingling in my left arm and hand.  It is most noticeable in my left hand. The numbness and tingling are present all the time, but sometimes it gets worse. It feels like my arm "fell asleep" all the time. My left arm is also sore to the touch. I thought this would pass, since arm pain is a common side-effect, but it has been 11 days and it has not improved and the numbness/tingling concern me, which is why I am reporting it now.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Cardiac flutter, Eye pain, Headache, Muscular weakness
Clinical narrative: Aching in joints specifically the knees Stiffness in fingers and puffiness Headache behind the eyes Heart fluttering and weakness in legs Ringing in ears
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Musculoskeletal stiffness, Peripheral swelling, Tinnitus
Clinical narrative: Aching in joints specifically the knees Stiffness in fingers and puffiness Headache behind the eyes Heart fluttering and weakness in legs Ringing in ears
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyskinesia, Fatigue, Muscle twitching, Myalgia, Palpitations
Clinical narrative: Aching in joints specifically the knees Stiffness in fingers and puffiness Headache behind the eyes Heart fluttering and weakness in legs Ringing in ears
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Tinnitus
Clinical narrative: Aching in joints specifically the knees Stiffness in fingers and puffiness Headache behind the eyes Heart fluttering and weakness in legs Ringing in ears
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chest X-ray, Fatigue, Jaundice, SARS-CoV-2 test
Clinical narrative: Pt came to ER for jaundice on 2/23.  Seen in ED again on 2/27 for weakness and fatigue.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Eating disorder, Gastritis, Oesophagitis, Pharyngeal erythema
Clinical narrative: First 5 days esophagitis/gastritis, red inflamed throat, epigastric pain, difficulty eating, reflux pain so bad awakens during night, difficulty taking meds. Started 8-10 days of Prilosec 40mg BID, then liquid diet and taper to Prilosec 20mg BID last 3 days. Awaiting availability to have gastric band released.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder
Clinical narrative: First 5 days esophagitis/gastritis, red inflamed throat, epigastric pain, difficulty eating, reflux pain so bad awakens during night, difficulty taking meds. Started 8-10 days of Prilosec 40mg BID, then liquid diet and taper to Prilosec 20mg BID last 3 days. Awaiting availability to have gastric band released.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pfizer on 4/8 and 4/29. Positive on 9/13
Age: 68.0
Sex: F
Vaccine: FLU4
Symptoms: Peripheral swelling
Clinical narrative: Swollen hands that were hard to open
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Chills, Confusional state, Fatigue, Headache
Clinical narrative: Fever >103, Bone pain, Confusion, Fatigue, Nausea, Muscle Pain, Chills, Rigors, Injection site pain, Headache.  Approximately 12 hours post vaccination Fever, chills, muscle pain, and headache began. These continued for the next 48 hours. Bone pain began approximately 24 hours post vaccination and continued for 12 hours. Fatigue began 36 hours post vaccination and still continues. Confusion began 94 hours post vaccination and still continues.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Myalgia, Nausea, Pyrexia
Clinical narrative: Fever >103, Bone pain, Confusion, Fatigue, Nausea, Muscle Pain, Chills, Rigors, Injection site pain, Headache.  Approximately 12 hours post vaccination Fever, chills, muscle pain, and headache began. These continued for the next 48 hours. Bone pain began approximately 24 hours post vaccination and continued for 12 hours. Fatigue began 36 hours post vaccination and still continues. Confusion began 94 hours post vaccination and still continues.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pfizer on 4/2 and 4/23 and 8/18. Positive on 9/13
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Vaccine positive rechallenge
Clinical narrative: I have been in menopause for 7 years.  After the 1st shot I noticed a return of hot flashes.  After the 2nd shot I have had them every day , now  for 6 months.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Moderna on 3/17 and 4/14. Positive on 9/13
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Blepharospasm
Clinical narrative: I have had both vaccines i had very harsh initial symptoms that went away after a few days however i have developed twitch in my left eye
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chronic obstructive pulmonary disease, Computerised tomogram thorax abnormal, Condition aggravated
Clinical narrative: Hospitalized;  COVID-19 positive (9.5.21);  fully vaccinated  Admission Date: 9/5/2021 Discharge Date: 09/10/2021  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is an 82 yo female with PMH of severe COPD, bronchiectasis, PE who was hospitalized on 9/5 with COVID19 pneumonia.   Onset of her symptoms were on 9/2. Patient had been vaccinated with Moderna earlier this year. Laboratory workup revealing for hyponatremia of 128 and positive COVID19 test. Hypoxic with ambulation in ED. CT Thorax showed post operative changes secondary to left lower lobectomy and extensive chronic lung changes with no notable acute process.   She was started on Decadron and Remdesivir and continued on home bronchodilators. We held home neb treatments secondary to COVID19 status. Her breathing and cough improved. PT/OT recommend Home with Home Care.   She was weaned to room air. Clinically stable for discharge on 9/8 but felt fatigued so monitored for 1 more night. On 9/10 - pt felt strong, back to baseline and ready to discharge home. She is discharged home in stable condition.   We discussed the following: - completion of Decadron for 4 more days (total of 10 days), THEN resuming home dose Prednisone - self quarantine through 9/1 - patient was recommended to monitor their oxygen levels at home with pulse oximeter and contact his PCP or call 911 if oxygen levels drop below 92%. Patient will need close follow up with PCP with additional outpatient testing/labs.  - Patient was provided COVID discharge instructions and to self monitor for any signs/symptoms of blood clots. We reviewed COVID self-isolation instructions.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cough, Dyspnoea, Fatigue, Hyponatraemia, Hypoxia
Clinical narrative: Hospitalized;  COVID-19 positive (9.5.21);  fully vaccinated  Admission Date: 9/5/2021 Discharge Date: 09/10/2021  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is an 82 yo female with PMH of severe COPD, bronchiectasis, PE who was hospitalized on 9/5 with COVID19 pneumonia.   Onset of her symptoms were on 9/2. Patient had been vaccinated with Moderna earlier this year. Laboratory workup revealing for hyponatremia of 128 and positive COVID19 test. Hypoxic with ambulation in ED. CT Thorax showed post operative changes secondary to left lower lobectomy and extensive chronic lung changes with no notable acute process.   She was started on Decadron and Remdesivir and continued on home bronchodilators. We held home neb treatments secondary to COVID19 status. Her breathing and cough improved. PT/OT recommend Home with Home Care.   She was weaned to room air. Clinically stable for discharge on 9/8 but felt fatigued so monitored for 1 more night. On 9/10 - pt felt strong, back to baseline and ready to discharge home. She is discharged home in stable condition.   We discussed the following: - completion of Decadron for 4 more days (total of 10 days), THEN resuming home dose Prednisone - self quarantine through 9/1 - patient was recommended to monitor their oxygen levels at home with pulse oximeter and contact his PCP or call 911 if oxygen levels drop below 92%. Patient will need close follow up with PCP with additional outpatient testing/labs.  - Patient was provided COVID discharge instructions and to self monitor for any signs/symptoms of blood clots. We reviewed COVID self-isolation instructions.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Laboratory test abnormal, Lung disorder, Patient isolation, Respiratory distress, Respiratory symptom
Clinical narrative: Hospitalized;  COVID-19 positive (9.5.21);  fully vaccinated  Admission Date: 9/5/2021 Discharge Date: 09/10/2021  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is an 82 yo female with PMH of severe COPD, bronchiectasis, PE who was hospitalized on 9/5 with COVID19 pneumonia.   Onset of her symptoms were on 9/2. Patient had been vaccinated with Moderna earlier this year. Laboratory workup revealing for hyponatremia of 128 and positive COVID19 test. Hypoxic with ambulation in ED. CT Thorax showed post operative changes secondary to left lower lobectomy and extensive chronic lung changes with no notable acute process.   She was started on Decadron and Remdesivir and continued on home bronchodilators. We held home neb treatments secondary to COVID19 status. Her breathing and cough improved. PT/OT recommend Home with Home Care.   She was weaned to room air. Clinically stable for discharge on 9/8 but felt fatigued so monitored for 1 more night. On 9/10 - pt felt strong, back to baseline and ready to discharge home. She is discharged home in stable condition.   We discussed the following: - completion of Decadron for 4 more days (total of 10 days), THEN resuming home dose Prednisone - self quarantine through 9/1 - patient was recommended to monitor their oxygen levels at home with pulse oximeter and contact his PCP or call 911 if oxygen levels drop below 92%. Patient will need close follow up with PCP with additional outpatient testing/labs.  - Patient was provided COVID discharge instructions and to self monitor for any signs/symptoms of blood clots. We reviewed COVID self-isolation instructions.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Spinal stenosis
Clinical narrative: Hospitalized;  COVID-19 positive (9.5.21);  fully vaccinated  Admission Date: 9/5/2021 Discharge Date: 09/10/2021  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is an 82 yo female with PMH of severe COPD, bronchiectasis, PE who was hospitalized on 9/5 with COVID19 pneumonia.   Onset of her symptoms were on 9/2. Patient had been vaccinated with Moderna earlier this year. Laboratory workup revealing for hyponatremia of 128 and positive COVID19 test. Hypoxic with ambulation in ED. CT Thorax showed post operative changes secondary to left lower lobectomy and extensive chronic lung changes with no notable acute process.   She was started on Decadron and Remdesivir and continued on home bronchodilators. We held home neb treatments secondary to COVID19 status. Her breathing and cough improved. PT/OT recommend Home with Home Care.   She was weaned to room air. Clinically stable for discharge on 9/8 but felt fatigued so monitored for 1 more night. On 9/10 - pt felt strong, back to baseline and ready to discharge home. She is discharged home in stable condition.   We discussed the following: - completion of Decadron for 4 more days (total of 10 days), THEN resuming home dose Prednisone - self quarantine through 9/1 - patient was recommended to monitor their oxygen levels at home with pulse oximeter and contact his PCP or call 911 if oxygen levels drop below 92%. Patient will need close follow up with PCP with additional outpatient testing/labs.  - Patient was provided COVID discharge instructions and to self monitor for any signs/symptoms of blood clots. We reviewed COVID self-isolation instructions.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Heavy menstrual bleeding, Intermenstrual bleeding
Clinical narrative: Severe menstruation cramping, heavy menstruation spotting/bleeding. Symptoms started one day after receiving vaccine with cramping. The next day followed by cramping and breakthrough spotting.  Very regular periods otherwise. Last period was sept 1-4th.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: I was traveling on 8/1/2021 and I started having symptoms on 8/6/2021. I did a Covid test and it was positive. We drove so we just got back into the car and came back home to quarantine.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Hypophagia, Injection site reaction, Injection site swelling, Malaise, Pain in extremity
Clinical narrative: My daughter had a 3 inch round raised welt at the injection site. It was about 1/8 inch raised for about 2 days and now 8 days later you can still see the red circle but its not raised. Also didn't feel well, didn't eat much for few days . Arm was sore like the first shot.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: My daughter had a 3 inch round raised welt at the injection site. It was about 1/8 inch raised for about 2 days and now 8 days later you can still see the red circle but its not raised. Also didn't feel well, didn't eat much for few days . Arm was sore like the first shot.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Deafness
Clinical narrative: About three days after the second dose of the Moderna covid 19 vaccine my grandfather has lost his hearing. He is no longer able to talk on the phone due to hearing loss. He lives alone so as you can see this is very very alarming.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient admitted 8/29/21 for generalized weakness and debility.Patient was negative for COVID on admission. Patient's ill wife was visiting patient. Patient documented to be COVID positive 9/10/21. Patient is currently still admitted for treatment at the time of this report.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Cervical radiculopathy, Condition aggravated, Fatigue, Fibromyalgia, Inflammation
Clinical narrative: In the afternoon of 9/11 I noted a flare of my fibromyalgia coming on.  I haven't had one in so long I can't remember the last one.  All of my old standard pain sites that hurt with a flare were inflamed, including a nerve issue in my neck, and I was exhausted.  The problem persists.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: In the afternoon of 9/11 I noted a flare of my fibromyalgia coming on.  I haven't had one in so long I can't remember the last one.  All of my old standard pain sites that hurt with a flare were inflamed, including a nerve issue in my neck, and I was exhausted.  The problem persists.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus which has progressively worsened
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness at the 15 minute mark after 1st dose of COVID vaccine. No other symptoms noted. BP 126/78, pulse 68, Resp. 18. After another 5 minutes,  patient has no complaints and states " feels back to normal"
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heavy menstrual bleeding, Polymenorrhoea
Clinical narrative: HEAVY EARLY PERIOD
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heavy menstrual bleeding, Menstruation irregular
Clinical narrative: HEAVY EARLY PERIOD
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Dyspnoea, Pulmonary thrombosis
Clinical narrative: Blood Clots both lungs, Hospital stay x4 days, shortness of breathe, heparin IV x3 days and oral blood thinner x6 months
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Nasal congestion, Pain, Pyrexia
Clinical narrative: NASAL CONGESTION, CHEST CONGESTION, COUGH, BODY ACHES, FEVER
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: NASAL CONGESTION, CHEST CONGESTION, COUGH, BODY ACHES, FEVER
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Urticaria
Clinical narrative: SWELLING WITH HIVES, SKIN REDNESS WITH ITCHING.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Palpitations
Clinical narrative: Whenever I walk up my stairs now my chest is tight and my heart is beating hard, im unable to catch my breath. this is 1 flight of stairs thats making me feel like i just ran a mile. really anything that gets my heart beating takes 90% faster to make me feel winded and needing time to get my heart to stop beating so fast. i didn't know if this was anxiety at first but it is now clear to me with my apple watch and checking my heart rate that it is indeed beating extremely fast after just minimal physical activity
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood creatinine normal, Blood sodium decreased, Bronchogenic cyst, COVID-19, COVID-19 pneumonia
Clinical narrative: Hospitalized;  COVID-19 positive (9.6.21);  fully vaccinated  Admission Date: 9/6/2021 Discharge Date:  09/11/2021  Discharge disposition: Home;  Condition at discharge: Improved Admission Diagnosis: Elevated troponin Congestive heart failure, unspecified HF chronicity, unspecified heart failure type Pneumonia due to COVID-19 virus COVID-19 Shock Syncope and collapse Discharge Diagnosis: COVID-19 Pneumonia Hospital Course:   Patient is a 54 year old male with past medical history of severe multivessel coronary artery disease S/p PCI April 2021 to LCx (previous PCI to LAD, uncontrolled diabetes mellitus type 2 (Hgb A1c 11.2), OSA, hypothyroidism, and recent diagnosis of COVID 19 presented to hospital with syncopal episode on 9/6. He reported he had had several syncopal episodes over past few weeks preceded by severe chest pain. Recent LHC 8/24/21- three vessel CAD with prior stent thrombosis, poor targets for revascularization. Echo 9/6- EF down to 32% from 44% in August. He did require 2L NC on presentation. Labs significant for sodium 128, Creat 0.64. Troponin 102 then increased to 668 then back down. He became hypotensive with concern for cardiogenic shock and he was started on norepi for MAP >65 and transferred to ICU for CTS evaluation for CABG. He was weaned off of vasopressors by AM 9/8. CTS stated patient not a CABG candidate due to distal CAD and COVID pneumonia. Transferred out of ICU 9/8.  He was started on dexamethasone and remdesivir for COVID pneumonia. He was hypotensive after transfer out of the ICU so unable to undergo diuresis or restart his home medications. Cardiology and Neurology felt that syncopal episodes were likely vasovagal in nature. Cardiology recommended medical management of CAD, LifeVest placed 9/10, repeat TTE in 3 months On CT thorax patient was found to have "A lobulated right lower paratracheal structure measures 2.5 x 3.2 cm and has gradually increased in size compared with 2009. This appeared to measure fluid density on the noncontrast portion of the comparison examination from 8/4/2017 and this may represent fluid in a pericardial recess or a bronchogenic/foregut cyst. However an abnormal mediastinal lymph node could also have this appearance. Recommend further assessment with MRI of the chest with and without contrast."  Will defer repeat imagine of this to PCP. PT evaluated the patient and recommended discharge home with outpatient PT. At discharge he is aware of 10 days isolation requirements for COVID-19, through 9/16 unless still having fevers. He has outpatient appointments established with PCP and Cardiology for follow-up.  Home ACE-I and IMDUR held at discharge for hypotension. He is encouraged to monitor BP at home and report to outpatient physicians. He has referral to outpatient cardiac rehab.  Diabetes followed through hospital stay and home medications were resumed at discharge.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac assistance device user, Cardiac failure, Cardiac failure congestive, Catheterisation cardiac, Chest pain
Clinical narrative: Hospitalized;  COVID-19 positive (9.6.21);  fully vaccinated  Admission Date: 9/6/2021 Discharge Date:  09/11/2021  Discharge disposition: Home;  Condition at discharge: Improved Admission Diagnosis: Elevated troponin Congestive heart failure, unspecified HF chronicity, unspecified heart failure type Pneumonia due to COVID-19 virus COVID-19 Shock Syncope and collapse Discharge Diagnosis: COVID-19 Pneumonia Hospital Course:   Patient is a 54 year old male with past medical history of severe multivessel coronary artery disease S/p PCI April 2021 to LCx (previous PCI to LAD, uncontrolled diabetes mellitus type 2 (Hgb A1c 11.2), OSA, hypothyroidism, and recent diagnosis of COVID 19 presented to hospital with syncopal episode on 9/6. He reported he had had several syncopal episodes over past few weeks preceded by severe chest pain. Recent LHC 8/24/21- three vessel CAD with prior stent thrombosis, poor targets for revascularization. Echo 9/6- EF down to 32% from 44% in August. He did require 2L NC on presentation. Labs significant for sodium 128, Creat 0.64. Troponin 102 then increased to 668 then back down. He became hypotensive with concern for cardiogenic shock and he was started on norepi for MAP >65 and transferred to ICU for CTS evaluation for CABG. He was weaned off of vasopressors by AM 9/8. CTS stated patient not a CABG candidate due to distal CAD and COVID pneumonia. Transferred out of ICU 9/8.  He was started on dexamethasone and remdesivir for COVID pneumonia. He was hypotensive after transfer out of the ICU so unable to undergo diuresis or restart his home medications. Cardiology and Neurology felt that syncopal episodes were likely vasovagal in nature. Cardiology recommended medical management of CAD, LifeVest placed 9/10, repeat TTE in 3 months On CT thorax patient was found to have "A lobulated right lower paratracheal structure measures 2.5 x 3.2 cm and has gradually increased in size compared with 2009. This appeared to measure fluid density on the noncontrast portion of the comparison examination from 8/4/2017 and this may represent fluid in a pericardial recess or a bronchogenic/foregut cyst. However an abnormal mediastinal lymph node could also have this appearance. Recommend further assessment with MRI of the chest with and without contrast."  Will defer repeat imagine of this to PCP. PT evaluated the patient and recommended discharge home with outpatient PT. At discharge he is aware of 10 days isolation requirements for COVID-19, through 9/16 unless still having fevers. He has outpatient appointments established with PCP and Cardiology for follow-up.  Home ACE-I and IMDUR held at discharge for hypotension. He is encouraged to monitor BP at home and report to outpatient physicians. He has referral to outpatient cardiac rehab.  Diabetes followed through hospital stay and home medications were resumed at discharge.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram thorax abnormal, Echocardiogram, Ejection fraction decreased, Hypotension, Intensive care
Clinical narrative: Hospitalized;  COVID-19 positive (9.6.21);  fully vaccinated  Admission Date: 9/6/2021 Discharge Date:  09/11/2021  Discharge disposition: Home;  Condition at discharge: Improved Admission Diagnosis: Elevated troponin Congestive heart failure, unspecified HF chronicity, unspecified heart failure type Pneumonia due to COVID-19 virus COVID-19 Shock Syncope and collapse Discharge Diagnosis: COVID-19 Pneumonia Hospital Course:   Patient is a 54 year old male with past medical history of severe multivessel coronary artery disease S/p PCI April 2021 to LCx (previous PCI to LAD, uncontrolled diabetes mellitus type 2 (Hgb A1c 11.2), OSA, hypothyroidism, and recent diagnosis of COVID 19 presented to hospital with syncopal episode on 9/6. He reported he had had several syncopal episodes over past few weeks preceded by severe chest pain. Recent LHC 8/24/21- three vessel CAD with prior stent thrombosis, poor targets for revascularization. Echo 9/6- EF down to 32% from 44% in August. He did require 2L NC on presentation. Labs significant for sodium 128, Creat 0.64. Troponin 102 then increased to 668 then back down. He became hypotensive with concern for cardiogenic shock and he was started on norepi for MAP >65 and transferred to ICU for CTS evaluation for CABG. He was weaned off of vasopressors by AM 9/8. CTS stated patient not a CABG candidate due to distal CAD and COVID pneumonia. Transferred out of ICU 9/8.  He was started on dexamethasone and remdesivir for COVID pneumonia. He was hypotensive after transfer out of the ICU so unable to undergo diuresis or restart his home medications. Cardiology and Neurology felt that syncopal episodes were likely vasovagal in nature. Cardiology recommended medical management of CAD, LifeVest placed 9/10, repeat TTE in 3 months On CT thorax patient was found to have "A lobulated right lower paratracheal structure measures 2.5 x 3.2 cm and has gradually increased in size compared with 2009. This appeared to measure fluid density on the noncontrast portion of the comparison examination from 8/4/2017 and this may represent fluid in a pericardial recess or a bronchogenic/foregut cyst. However an abnormal mediastinal lymph node could also have this appearance. Recommend further assessment with MRI of the chest with and without contrast."  Will defer repeat imagine of this to PCP. PT evaluated the patient and recommended discharge home with outpatient PT. At discharge he is aware of 10 days isolation requirements for COVID-19, through 9/16 unless still having fevers. He has outpatient appointments established with PCP and Cardiology for follow-up.  Home ACE-I and IMDUR held at discharge for hypotension. He is encouraged to monitor BP at home and report to outpatient physicians. He has referral to outpatient cardiac rehab.  Diabetes followed through hospital stay and home medications were resumed at discharge.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy mediastinal, Percutaneous coronary intervention, Pericardial effusion, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Hospitalized;  COVID-19 positive (9.6.21);  fully vaccinated  Admission Date: 9/6/2021 Discharge Date:  09/11/2021  Discharge disposition: Home;  Condition at discharge: Improved Admission Diagnosis: Elevated troponin Congestive heart failure, unspecified HF chronicity, unspecified heart failure type Pneumonia due to COVID-19 virus COVID-19 Shock Syncope and collapse Discharge Diagnosis: COVID-19 Pneumonia Hospital Course:   Patient is a 54 year old male with past medical history of severe multivessel coronary artery disease S/p PCI April 2021 to LCx (previous PCI to LAD, uncontrolled diabetes mellitus type 2 (Hgb A1c 11.2), OSA, hypothyroidism, and recent diagnosis of COVID 19 presented to hospital with syncopal episode on 9/6. He reported he had had several syncopal episodes over past few weeks preceded by severe chest pain. Recent LHC 8/24/21- three vessel CAD with prior stent thrombosis, poor targets for revascularization. Echo 9/6- EF down to 32% from 44% in August. He did require 2L NC on presentation. Labs significant for sodium 128, Creat 0.64. Troponin 102 then increased to 668 then back down. He became hypotensive with concern for cardiogenic shock and he was started on norepi for MAP >65 and transferred to ICU for CTS evaluation for CABG. He was weaned off of vasopressors by AM 9/8. CTS stated patient not a CABG candidate due to distal CAD and COVID pneumonia. Transferred out of ICU 9/8.  He was started on dexamethasone and remdesivir for COVID pneumonia. He was hypotensive after transfer out of the ICU so unable to undergo diuresis or restart his home medications. Cardiology and Neurology felt that syncopal episodes were likely vasovagal in nature. Cardiology recommended medical management of CAD, LifeVest placed 9/10, repeat TTE in 3 months On CT thorax patient was found to have "A lobulated right lower paratracheal structure measures 2.5 x 3.2 cm and has gradually increased in size compared with 2009. This appeared to measure fluid density on the noncontrast portion of the comparison examination from 8/4/2017 and this may represent fluid in a pericardial recess or a bronchogenic/foregut cyst. However an abnormal mediastinal lymph node could also have this appearance. Recommend further assessment with MRI of the chest with and without contrast."  Will defer repeat imagine of this to PCP. PT evaluated the patient and recommended discharge home with outpatient PT. At discharge he is aware of 10 days isolation requirements for COVID-19, through 9/16 unless still having fevers. He has outpatient appointments established with PCP and Cardiology for follow-up.  Home ACE-I and IMDUR held at discharge for hypotension. He is encouraged to monitor BP at home and report to outpatient physicians. He has referral to outpatient cardiac rehab.  Diabetes followed through hospital stay and home medications were resumed at discharge.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Shock, Syncope, Troponin increased
Clinical narrative: Hospitalized;  COVID-19 positive (9.6.21);  fully vaccinated  Admission Date: 9/6/2021 Discharge Date:  09/11/2021  Discharge disposition: Home;  Condition at discharge: Improved Admission Diagnosis: Elevated troponin Congestive heart failure, unspecified HF chronicity, unspecified heart failure type Pneumonia due to COVID-19 virus COVID-19 Shock Syncope and collapse Discharge Diagnosis: COVID-19 Pneumonia Hospital Course:   Patient is a 54 year old male with past medical history of severe multivessel coronary artery disease S/p PCI April 2021 to LCx (previous PCI to LAD, uncontrolled diabetes mellitus type 2 (Hgb A1c 11.2), OSA, hypothyroidism, and recent diagnosis of COVID 19 presented to hospital with syncopal episode on 9/6. He reported he had had several syncopal episodes over past few weeks preceded by severe chest pain. Recent LHC 8/24/21- three vessel CAD with prior stent thrombosis, poor targets for revascularization. Echo 9/6- EF down to 32% from 44% in August. He did require 2L NC on presentation. Labs significant for sodium 128, Creat 0.64. Troponin 102 then increased to 668 then back down. He became hypotensive with concern for cardiogenic shock and he was started on norepi for MAP >65 and transferred to ICU for CTS evaluation for CABG. He was weaned off of vasopressors by AM 9/8. CTS stated patient not a CABG candidate due to distal CAD and COVID pneumonia. Transferred out of ICU 9/8.  He was started on dexamethasone and remdesivir for COVID pneumonia. He was hypotensive after transfer out of the ICU so unable to undergo diuresis or restart his home medications. Cardiology and Neurology felt that syncopal episodes were likely vasovagal in nature. Cardiology recommended medical management of CAD, LifeVest placed 9/10, repeat TTE in 3 months On CT thorax patient was found to have "A lobulated right lower paratracheal structure measures 2.5 x 3.2 cm and has gradually increased in size compared with 2009. This appeared to measure fluid density on the noncontrast portion of the comparison examination from 8/4/2017 and this may represent fluid in a pericardial recess or a bronchogenic/foregut cyst. However an abnormal mediastinal lymph node could also have this appearance. Recommend further assessment with MRI of the chest with and without contrast."  Will defer repeat imagine of this to PCP. PT evaluated the patient and recommended discharge home with outpatient PT. At discharge he is aware of 10 days isolation requirements for COVID-19, through 9/16 unless still having fevers. He has outpatient appointments established with PCP and Cardiology for follow-up.  Home ACE-I and IMDUR held at discharge for hypotension. He is encouraged to monitor BP at home and report to outpatient physicians. He has referral to outpatient cardiac rehab.  Diabetes followed through hospital stay and home medications were resumed at discharge.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Facial paralysis, Headache, Magnetic resonance imaging head normal
Clinical narrative: Bell?s Palsy Drooping face, headache
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Fatigue, Headache, Hyperhidrosis
Clinical narrative: Fatigue staring 24 hours after vaccination and lasting 48 hours. Headache 72 hours after vaccination.  Sweats and chills, cough, nausea and vomiting all  72 hours after vaccination.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Fatigue staring 24 hours after vaccination and lasting 48 hours. Headache 72 hours after vaccination.  Sweats and chills, cough, nausea and vomiting all  72 hours after vaccination.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Erythema, Headache, Impaired work ability
Clinical narrative: Within 30 minutes I was very nauseous (10 on a scale of one to ten). Then headache started in frontal lobe area (reminds me of when I had covid in 2/2020 and doesn't respond to anything).  Slight itchiness. Lots of pain (widespread body pain not body aches). By 10 hours the pain was preventing sleep and the chills were causing shivering. Fever is steady between 101-102. I'm very itchy now (arms, chest, face, legs 6 on a scale of one to ten) with slight redness to chest/face. Briefly had pain with deep breaths but that has stopped. I've got major frequent urination (about every 30mins, not drinking much due to nausea). Shoulders are both hurting and stiff (not necessarily uncommon). I  literally feel worse than having covid and I had to call in to work.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pleurisy, Pollakiuria, Pruritus
Clinical narrative: Within 30 minutes I was very nauseous (10 on a scale of one to ten). Then headache started in frontal lobe area (reminds me of when I had covid in 2/2020 and doesn't respond to anything).  Slight itchiness. Lots of pain (widespread body pain not body aches). By 10 hours the pain was preventing sleep and the chills were causing shivering. Fever is steady between 101-102. I'm very itchy now (arms, chest, face, legs 6 on a scale of one to ten) with slight redness to chest/face. Briefly had pain with deep breaths but that has stopped. I've got major frequent urination (about every 30mins, not drinking much due to nausea). Shoulders are both hurting and stiff (not necessarily uncommon). I  literally feel worse than having covid and I had to call in to work.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Sleep disorder
Clinical narrative: Within 30 minutes I was very nauseous (10 on a scale of one to ten). Then headache started in frontal lobe area (reminds me of when I had covid in 2/2020 and doesn't respond to anything).  Slight itchiness. Lots of pain (widespread body pain not body aches). By 10 hours the pain was preventing sleep and the chills were causing shivering. Fever is steady between 101-102. I'm very itchy now (arms, chest, face, legs 6 on a scale of one to ten) with slight redness to chest/face. Briefly had pain with deep breaths but that has stopped. I've got major frequent urination (about every 30mins, not drinking much due to nausea). Shoulders are both hurting and stiff (not necessarily uncommon). I  literally feel worse than having covid and I had to call in to work.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pain, Pain in extremity, Sleep disorder
Clinical narrative: 7 days after receiving the first dose of Moderna I developed lasting arm pain. This was different from the arm pain/soreness I had 3 hours after I first received the shot (which only lasted 2 days). Once the initial soreness wore off I had no pain, and then 7 days after the injection I developed this lasting arm pain at the site of injection. It can range from a dull ache, to intermittent sharp pains that radiate down from the site of injection to the base of my deltoid muscle. Sometimes it will keep me up at night, and seems to get worse when it's going to rain.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: Fever to 103F. Profound headache, chills, rigors and body aches.  Lasted for total of 5 days; fever resolved on day 6. Symptom free (other than low grade fever ) on day 5.
Age: 96.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Nausea, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Presented to EC c/o nausea & vomiting on 04/24/21; discharged back to Facility on 04/29/21.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Paraesthesia
Clinical narrative: 8/13/2021: Patient 37w 6d gestation with EDD 8/28/2021. Pt presented with regular, painful contractions every 1-2 minutes with some bloody mucous discharge, but no leakage of fluid. Pt desires repeat cesarean delivery with tubal ligation.  Patient tolerated Cesarean procedure well. COVID-19 test had not resulted prior to procedure, as it was considered urgent/emergent. No postop/postpartum problems. 8/15/2021: Patient given first dose of Pfizer COVID-19 vaccine. Pt stated that she feels like her "left side of face feels tingly/numb." Vitals WNL. Around 1443, patient stated that she started to have a headache. Earlier today, patient discharged postpartum c-section.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Erythema, Peripheral swelling
Clinical narrative: Swollen lower leg , redness , blisters